| ¿µ¹® | septal defects of heart | ÇÑ±Û | ½ÉÀåÀÇ Áß°Ý °á¼Õ |
|---|---|---|---|
| ¼³¸í | ¼±ÃµÀûÀ¸·Î ½ÉÀå ³»ÀÇ ½É¹æ»çÀÌÁß°Ý(interatrial septum)À̳ª ½É½Ç»çÀÌÁß°Ý(interventricular septum)ÀÌ °á¼ÕµÇ¾î Ç÷·ù°¡ Á¤»óÀûÀ¸·Î È帣Áö ¾Ê´Â °æ¿ì. Á¤»óÀûÀÎ °æ¿ì Ç÷·ù´Â Á¤¸Æ¿¡¼ ¿ì½É¹æÀ¸·Î ¸ð¿© ¿ì½É½ÇÀ» °ÅÄ£µÚ Æó·Î °¡¼ »ê¼Ò¸¦ °ø±Þ¹Þ°í ´Ù½Ã ¿Þ½É¹æ, ¿Þ½É½ÇÀ» Â÷·Ê·Î °ÅÃÄ ´ëµ¿¸ÆÀ¸·Î °£´Ù. ÇÏÁö¸¸, ÀÌ °æ¿ì´Â Ç÷·ù°¡ ¾Ð·ÂÀÌ ³ôÀº ¿Þ½É¹æÀ̳ª ¿Þ½É½Ç¿¡¼ ¾Ð·ÂÀÌ ³·Àº ¿ì½É¹æÀ̳ª ¿ì½É½Ç·Î È帣°Ô µÈ´Ù. µû¶ó¼ µ¿¸ÆÇÇ¿Í Á¤¸ÆÇǰ¡ ¼¯ÀÌ°Ô µÇ°í, ȯÀڴ ȣÈí°ï¶õ, ¼ºÀå¹ßÀ°Àå¾Ö, ½ÉÀâÀ½ µîÀÌ ³ªÅ¸³ª°í, ½ÉÇÑ °æ¿ì û»öÁõÀ¸·Î ¹ßÀüÇϱ⵵ ÇÑ´Ù. Ä¡·á´Â ¼ö¼úÀûÀ¸·Î ÀÌ °á¼ÕºÎÀ§¸¦ ¸·¾Æ ÁÖ¾î¾ß ÇÑ´Ù. |
||
| PHAVER | pterygia-heart defects-autosomal recessive inheritance-vertebral defects-ear anomalies-radial defect... |
|---|---|
| FDP | fibrin degradation product; fibrinogen degradation product; flexor digitorum profundus; frontodextra... |
| PD | Doctor of Pharmacy; Dublin Pharmacopoeia; interpupillary distance; Paget disease; pancreatic duct; p... |
| SGP | serine glycerophosphatide; sialoglycoprotein; Society of General Physiologists; soluble glycoprotein... |
| FDP(s) | 1) Fibrinolytic split Products(= FSP) 2) Fibrinogen Degradation Products |
| AVSD | Atrio ventricular septal defects |
|---|---|
| BDMP | Birth Defects Monitoring Program |
| LRD | Limb reduction defects |
| MACDP | Metropolitan Atlanta Congenital Defects Program |
| MLS | Microphthalmia with linear skin defects |
| degradation | <biochemistry, chemistry> The reduction of a chemical compound to one less complex, as by splitting off one or more groups. (18 Nov 1997) |
|---|---|
| edman degradation | A lab technique used to find out the order of amino acids in a polypeptide (chain of amino acids). It involves using the Edman reagent, phenyl isothiocyanate (PITC), to react one by one with each amino acid, in order. The technique is used in machines which automatically sequence (determine the order of subunits) polypeptides. (09 Oct 1997) |
| fibrin degradation products | <haematology, investigation> A test that measures fibrin degradation products which result from the dissolution of a blood clot. Normal value is less than 10 mcg/ml (micrograms per millilitre). They may be increased in conditions such as burns, placental abruption, heart disease, DIC, after massive blood transfusion, hypoxia, intrauterine foetal death, portacaval shunt, leukaemia, transfusion reaction, transplant rejection, sepsis, renal failure and preeclampsia. Acronym: FDP (23 Sep 2002) |
| fibrin fibrinogen degradation products | <chemical> Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. Fdp and their complexes profoundly impair the haemostatic process and are a major cause of haemorrhage in intravascular coagulation and fibrinolysis. Pharmacological action: antithrombins. (12 Dec 1998) |
| gastric filling defects | <radiology> Malignant tumours, carcinoma, lymphoma, leiomyosarcoma, metastases, benign, leiomyoma, lipoma, neurofibroma, polyp, hyperplastic, adenomatous, hamartomatous, others, bezoar, Nissen fundoplication, ectopic pancreas (12 Dec 1998) |
| midline closure defects | <radiology> Anencephaly, encephalocele, 70% occipital, 20% parietal or frontal, 10% basal, agenesis of corpus callosum associated with increased alpha-fetoprotein. (12 Dec 1998) |
| colour vision defects | Mild to severe impairment in the ability to discriminate or differentiate hues. This disorder may be acquired as a result of diseases of the cones or x chromosome-linked where there is an abnormality but not a complete absence of one of the cone pigments. (12 Dec 1998) |
| heart defects, congenital | Imperfections or malformations of the heart, existing at birth. (12 Dec 1998) |
| heart septal defects | Defects in the cardiac septa, resulting in abnormal communications between the opposite chambers of the heart. (12 Dec 1998) |
| heart septal defects, atrial | Defects in the septum between the atria of the heart, due to failure of fusion between either the septum secundum or the septum primum and the endocardial cushions. (12 Dec 1998) |
| heart septal defects, ventricular | Congenital defects in the septum between the cardiac ventricles, most often due to failure of the bulbar septum to completely close the interventricular foramen. (12 Dec 1998) |
| endocardial cushion defects | A spectrum of septal defects associated with persistence of the embryonic atrioventricular canal due to incomplete growth and fusion of the endocardial cushion. (12 Dec 1998) |
| furcation defects | Conditions in which a bifurcation or trifurcation of the molar tooth root becomes denuded as a result of periodontal disease. It may be followed by tooth mobility, temperature sensitivity, pain, and alveolar bone resorption. (12 Dec 1998) |
| a1-acid glycoprotein | <biology> Plasma protein of mammals and birds, 38% carbohydrate. In humans a single chain glycoprotein of 39 kD. Increased levels are associated with inflammation, pregnancy and various diseases. (18 Nov 1997) |
| acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase | <enzyme> Forms oligosaccharide core class 3 (glcnac beta 1-3galnac) in mucins and various glycoproteins Registry number: EC 2.4.1.147 Synonym: udp-glcnac-galnac-r beta 3-acetylglucosaminyltransferase, agggag-transferase (26 Jun 1999) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|